Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
PLoS Med
; 5(1): e8, 2008 Jan 22.
Article
in En
| MEDLINE
| ID: mdl-18215105
Full text:
1
Database:
MEDLINE
Main subject:
Protein Kinases
/
Brain Neoplasms
/
Salvage Therapy
/
Glioblastoma
/
Sirolimus
/
Protein Kinase Inhibitors
/
PTEN Phosphohydrolase
/
Neoplasm Proteins
/
Antineoplastic Agents
Type of study:
Prognostic_studies
/
Qualitative_research
Language:
En
Journal:
PLoS Med
Journal subject:
MEDICINA
Year:
2008
Type:
Article
Affiliation country:
United States